Get the Stockscreener App
3.12
2.63%
0.08
After Hours:
3.20
0.08
+2.56%
Overview
News
Price History
Option Chain
Financials
Why PETS Down?
Discussions
Forecast
Stock Split
Dividend History
Petmed Express Inc stock is traded at $3.12, with a volume of 144.80K.
It is up +2.63% in the last 24 hours and down -10.60% over the past month.
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.
See More
Previous Close:
$3.04
Open:
$3.05
24h Volume:
144.80K
Relative Volume:
1.12
Market Cap:
$64.45M
Revenue:
$270.52M
Net Income/Loss:
$-6.08M
P/E Ratio:
-10.60
EPS:
-0.2944
Net Cash Flow:
$17.42M
1W Performance:
-8.50%
1M Performance:
-10.60%
6M Performance:
-38.94%
1Y Performance:
-20.71%
1-Day Range:
$3.05
$3.2097
1-Week Range:
$3.00
$3.3995
52-Week Range:
$2.90
$6.85
Petmed Express Inc Stock (PETS) Company Profile
Name
Petmed Express Inc
Sector
Industry
Phone
(561) 426-4444
Address
420 SOUTH CONGRESS AVENUE, DELRAY BEACH
Compare PETS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PETS
Petmed Express Inc
|
3.12 | 70.44M | 270.52M | -6.08M | 17.42M | -0.2944 |
|
WBA
Walgreens Boots Alliance Inc
|
11.51 | 10.01B | 151.95B | -5.78B | 571.00M | -6.69 |
|
HITI
High Tide Inc
|
2.50 | 193.68M | 376.07M | -22.41M | 18.73M | -0.298 |
|
WGRX
Wellgistics Health Inc
|
0.92 | 71.86M | 0 | 0 | 0 | 0.00 |
|
SCNX
Scienture Holdings Inc
|
2.08 | 21.51M | 0 | 0 | 0 | 0.00 |
Petmed Express Inc Stock (PETS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-25-23 | Initiated | Lake Street | Buy |
| Jan-20-22 | Upgrade | Sidoti | Neutral → Buy |
| Nov-18-21 | Initiated | Morgan Stanley | Underweight |
| Oct-01-21 | Initiated | Jefferies | Hold |
| Aug-05-21 | Resumed | Credit Suisse | Underperform |
| Jun-03-21 | Downgrade | Sidoti | Buy → Neutral |
| Mar-05-21 | Upgrade | Sidoti | Neutral → Buy |
| Jan-27-21 | Downgrade | Sidoti | Buy → Neutral |
| Aug-19-20 | Upgrade | Sidoti | Neutral → Buy |
| Apr-09-20 | Downgrade | Sidoti | Buy → Neutral |
| Mar-12-20 | Upgrade | Sidoti | Neutral → Buy |
| Feb-24-20 | Downgrade | Sidoti | Buy → Neutral |
| Aug-16-19 | Downgrade | Craig Hallum | Buy → Hold |
| Jun-15-18 | Initiated | CL King | Neutral |
| Aug-24-17 | Upgrade | Sidoti | Neutral → Buy |
| Jul-24-17 | Upgrade | Northcoast | Neutral → Buy |
| May-09-16 | Upgrade | Craig Hallum | Sell → Hold |
| Feb-04-16 | Initiated | Credit Suisse | Underperform |
| Jul-19-10 | Downgrade | CL King | Strong Buy → Accumulate |
| Jul-19-10 | Reiterated | JMP Securities | Mkt Outperform |
| May-25-10 | Downgrade | Wedbush | Neutral → Underperform |
| May-06-10 | Reiterated | Wedbush | Neutral |
| Mar-23-10 | Downgrade | Janney Mntgmy Scott | Buy → Neutral |
| Mar-18-10 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Feb-16-10 | Reiterated | CL King | Strong Buy |
| Jul-21-09 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Jan-07-09 | Initiated | CL King | Strong Buy |
View All
Petmed Express Inc Stock (PETS) Latest News
PETMED INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire
Why PetMed Express Inc. stock attracts strong analyst attentionFree Stock Selection with 300% Return - Newser
How PetMed Express Inc. stock performs during market volatilityLow Risk Consistent Winners - Newser
What makes PetMed Express Inc. stock price move sharplyTop Momentum Stock Pick - Newser
Bragar Eagel & Squire, P.C Continues Investigations on - GlobeNewswire
PetMed Express (PETS): Red Flags in Delayed Reporting Signal Governance and Fraud Risks - AInvest
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc.PETS - WV News
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces an - GlobeNewswire
PetMed Express Investors Should Contact Block & Leviton to Find Out How They Might Recover Losses Through The Firm’s Investigation - Louisiana First News
Silvercape investments buys Petmed Express (PETS) shares worth $9,070 By Investing.com - Investing.com
PetMeds receives Nasdaq non-compliance notice over delayed annual report - Investing.com
PetMed Express Faces Nasdaq Filing Compliance Notice - TipRanks
PetMeds receives Nasdaq non-compliance notice over delayed annual report By Investing.com - Investing.com Nigeria
PetMed Express, Inc. Receives Nasdaq Notice for Non-Compliance with Filing Requirements - Quiver Quantitative
PetMed Express Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K - TradingView
Wagmo Collabs With PetMeds for Pet Benefits for Employees, Travel + Leisure Co. Pa - Loyalty360
PetMeds delays 10-K filing amid whistleblower investigation By Investing.com - Investing.com Canada
PETS Investor ALERT: Block & Leviton Investigating PetMed Express For Possible Securities ... - Bluefield Daily Telegraph
PetMed Express, Inc. Provides Update on Fourth Quarter and FY 2025 Results Amid Audit Investigation - Quiver Quantitative
PETMED ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
PetMed Express Under Scrutiny: How Delayed Financial Reporting Signals Investor Risk - AInvest
PetMeds Launches Major Pet Health Savings Program: Members Get Instant $25 Credit Through Wagmo Partnership - Stock Titan
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed ... - Bluefield Daily Telegraph
PetMed Express (NASDAQ:PETS) Rating Lowered to “Sell” at Wall Street Zen - Defense World
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed - Bluefield Daily Telegraph
PetMeds reports preliminary Q4 sales decline, delays annual filing By Investing.com - Investing.com India
PetMed Express sees Q4 net sales between $51.1M and $53.1M - MSN
PetMed Express Delays Filing of Annual Report - TipRanks
PetMed Express (PETS) Projects Decline in Q4 Sales and Earnings - GuruFocus
PetMed Express Inc (PETS) Q4 2025 Earnings: Revenue Misses Estimate at $51.1M-$53.1M, Net Loss Widens - GuruFocus
PetMed Express, Inc. Announces Preliminary Fourth Quarter and FY 2025 Results and Filing of Form 12b-25 - The Manila Times
PetMed Express, Inc. Announces Preliminary Fourth Quarter and FY 2025 Results and Filing of Form 12b-25 | PETS Stock News - GuruFocus
PETS Reports Expected Drop in Q4 Net Sales and Increased Net Loss | PETS Stock News - GuruFocus
Petmed Express, Inc. Announces Preliminary Fourth Quarter And FY 2025 Results And Filing Of Form 12B-25 - MarketScreener
PetMeds Reports Major Revenue Drop and Delayed Filing: Q4 Sales Plunge $15M as Losses Double - Stock Titan
PetMed Express (PETS) Awaits Q4 Earnings with Improved EPS Outlo - GuruFocus
Bank of America Corp DE Grows Stake in PetMed Express, Inc. (NASDAQ:PETS) - Defense World
PetMeds delays Q4 and fiscal 2025 earnings release By Investing.com - Investing.com India
Dog Owner Defends Tick Meds Suit Against Elanco, Retailers - Law360
PetMed Express (PETS) Shares Fall Amid Financial Results Delay - GuruFocus
PetMed Express Delays Fiscal Q4 Results - MarketScreener
PetMed Express delays FQ4 results (PETS:NASDAQ) - Seeking Alpha
PetMeds delays Q4 and fiscal 2025 earnings release - Investing.com Australia
PetMed Express, Inc. Announces Delay in Fourth Quarter and Fisca - GuruFocus
PetMed Express Delays 4Q Financial Report - MarketWatch
PetMed Express Announces Delay in Q4 and Fiscal Year Results - marketscreener.com
PetMed Express, Inc. Announces Delay in Fourth Quarter and Fiscal Year End Earnings Release and Conference Call - The Manila Times
PetMeds Earnings Release Postponed: Extended Audit Process Raises Questions About Q4 Results - Stock Titan
PetMed Express, Inc. (NASDAQ:PETS) Stock Holdings Boosted by Squarepoint Ops LLC - Defense World
Earnings To Watch: PetMed Express Inc (PETS) Reports Q4 2025 Result - Yahoo Finance
Earnings To Watch: PetMed Express Inc (PETS) Reports Q4 2025 Res - GuruFocus
Petmed Express Inc Stock (PETS) Financials Data
Revenue
Net Income
Cash Flow
EPS
8.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):